The Link between Diabetes and Cardiovascular Disease

Journal of Pharmacy Practice

Volumn 17, Issue 1, 2004, Pages 61-65

  Schering, Deb ^a,b   Kasten, Shelia ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b FERRIS STATE UNIVERSITY   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Aspirin; Cardiovascular disease; Cholesterol; Diabetes; Lipids

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; SIMVASTATIN; STATINE; THROMBOXANE;

ARTHRALGIA; BACKACHE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; DEATH; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DYSLIPIDEMIA; DYSPEPSIA; FLUSHING; GALLSTONE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INCIDENCE; LIPID BLOOD LEVEL; LIVER TOXICITY; MORBIDITY; MORTALITY; MYOPATHY; OBESITY; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SIDE EFFECT; VASOCONSTRICTION;

EID: 1642579597     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1177/0897190003261310     Document Type: Review

References (17)

1. American Diabetes Association. National diabetes fact sheet. Retrieved August 2, 2003, from www.diabetes.org.
2. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;21:1551-1559.
3. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
4. Haffner S, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
5. Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316:823-828.
6. Talbert RL. Hyperlipidemia. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 5th ed. Chicago, Ill: McGraw-Hill; 2002:395-417.
7. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003;26:S83-S86.
8. Haffner S. Management of dyslipidemia in adults with diabetes. Diabetes Care. 1998;21:160-178.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet. 2003;361:2005-2016.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
11. Ezetimibe (Zetia) prescribing information. North Wales, PA: Merck/Schering-Plough Pharmaceuticals; 2002.
12. Davi G, Catalano I, Averna M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990;322:1769-1774.
13. Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet. 2001;357:89-95.
14. Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomized trial of low intensity oral anticoagulation with warfarin and low dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. Lancet. 1998;351:233-241.
15. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
16. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 2003;26:S87-S88.
17. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:71-72,81-106.